INVIZYNE TECHNOLOGIES INC

IPO

Next Generation Biomanufacturing

Monrovia, United States · Founded 2019 · $2.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$2.0M
Last Round
$2.0M Grant

About

Invizyne Technologies (now rebranding as eXoZymes) is a cell-free biomanufacturing company that uses enzyme-based technology to produce fuels, foods, medicines, and specialty chemicals sustainably. The company's Cell-Free Biomanufacturing platform overcomes limitations of first-generation synthetic biology by liberating chemical manufacturing from biological cell constraints. Invizyne completed a Nasdaq IPO in November 2024 and has proven its platform in cannabinoids, biofuels, and terpene production.

Summary

INVIZYNE TECHNOLOGIES INC is a Biotech company based in Monrovia, United States, founded in 2019. It has raised $2.0M in total.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

No funding data available yet.

Know something? Help us improve our data.

Similar Companies